SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai ($BBAI) is trending amid discussions about its acquisition of Ask Sage, an AI platform, and anticipation for the earnings call. The community is focused on the potential revenue from Ask Sage and its role in AI defense, with some hoping for significant stock movement soon. Recent after-hours momentum and AI sector strength may also be contributing to the increased attention.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is trending due to an after-hours tumble following its earnings report, despite a revenue beat; the company's lowered guidance is the primary concern, overshadowing positive metrics such as backlog growth. Community discussion revolves around whether this drop presents a buying opportunity or signals deeper issues, particularly related to revenue recognition and data center delays. Some traders believe the dip is an overreaction and a temporary setback for this AI infrastructure play.

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is trending as chatter increases around potential adoption by governments and its role in providing data to platforms like Kalshi. Community members are speculating on the potential impact of real-world asset (RWA) integration and comparing it to other cryptocurrencies.

Biggie is a popular Pitbull across several social media platforms, such as Tiktok, Youtube and Instagram. With a blend of creativity and comedic gestures, Biggie brings animal loving entertainment to millions of viewers through images, videos and reels. With Biggie the Pitbull's growing popularity, the meme coin $BIGGIE was inspired and launched on the ethereum network, leveraging Biggies unique sense of humor and style.

Biggie

Biggie is gaining attention, trending on multiple platforms, and experiencing increased trading volume. Community members are excited about its potential, drawing comparisons to other meme coins and highlighting the burned liquidity as a safety measure. There is also excitement around new traders joining the community.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending as the community discusses the potential impact of a new CEO pay package and the upcoming R2 model launch. Bullish sentiment seems to be fueled by strong volume and the anticipation of Rivian's AI and Autonomy Day in December. Some investors are drawing parallels to Tesla's growth trajectory, while others remain cautious, citing profitability concerns.

UNI is the governance token for Uniswap, an Automated Market Marker DEX on the Ethereum blockchain. The UNI token allows token holders to participate in the governance of the protocol. Key decisions such as usage of the treasury or future upgrades can be decided through a governance vote.

UniSwap

Uniswap ($UNI) is trending as traders discuss its potential for significant gains and its strong technical setup. The community is actively watching for breakout opportunities and anticipating a potential surge, drawing comparisons to previous altcoin season patterns. Some users are pointing to the protocol's strong fundamentals, including substantial fee generation, as a reason for optimism.

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.

Anavex Life Sciences Corporation

Anavex Life Sciences Corp

AVXL is trending amid anticipation for the CHMP opinion on its Alzheimer's drug, Blarcamesine, with a decision potentially arriving soon. Community discussions revolve around the likelihood of approval, the potential for a short squeeze, and speculation on future partnerships. Some believe approval is imminent due to the drug's safety profile and convenience compared to existing treatments, while others remain cautious, awaiting the official announcement.

Galecto, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3 and LOXL2. The company was founded by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye in 2011 and is headquartered in Boston, MA.

Galecto Inc

Galecto (GLTO) is trending after announcing its acquisition of Damora Therapeutics and a significant private placement, sparking a massive surge in price and volume. The community is actively discussing the potential for a short squeeze due to the low float and high cost to borrow, while some traders are wary of a potential pump and dump. GLTO's strategic shift toward hematologic malignancies, driven by mutated calreticulin, has also captured the attention of investors in the biotech sector.

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending as investors discuss its recent delivery numbers and potential path to profitability, while also comparing its performance and strategy to competitors like Xpeng and Tesla. Community talking points include concerns about stock dilution and the effectiveness of NIO's battery swapping technology. The stock's movement relative to peers and the broader market seems to be fueling frustration and debate among investors.

Welcome to SLAP – The Only Coin That Slaps Harder Than Your Moms  Tired of coins that claim they SLAP but are nothing but limp wrists? SLAP is here to SLAP some sense into the crypto space.  Founded by the Flutter of Five Fingers and powered by the Prancing of the Pried Palm, SLAP isn’t just another coin—it’s an attitude.  We’re not here to talk roadmaps, utility, or world peace. We’re here to SLAP charts, SLAP the haters, and SLAP our way to the top. No VC suits, no corporate nonsense—just raw, unfiltered internet culture with a side of “did we just do that?  ”So load your wallet, mute your financial advisor, and get ready to ride the most unhinged meme rocket. Open up your hands, and start swingin'. You never know what you could hit.  SLAP: It’s not a coin. It’s a lifestyle.

Slap

The crypto meme coin $SLAP is trending as the community rallies around its catchy name and simple concept. Social media mentions, brand partnerships, and community enthusiasm are driving conversation, with many expressing a shared belief in the project's potential for success using the acronym WAGMI (We're All Gonna Make It). The coin is built on the BASE network and the community references slapping bears, $TRUMP, and other cryptos such as $ETH, $BTC, and $SOL.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Neurocrine Biosciences Provides Update on Phase 2 Study of NBI-1070770 in Adults with Major Depressive Disorder

Neurocrine Biosciences Provides Update on Phase 2 Study of NBI-1070770 in Adults with Major Depressive Disorder Neurocrine Biosciences Provides Update on Phase 2 Study of NBI-1070770 in Adults with...

Pier 88 Investment Partners LLC Sells 3,680 Shares of Neurocrine Biosciences, Inc. $NBIX

Pier 88 Investment Partners LLC cut its stake in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 43.0% in the 2nd quarter, according to its most recent Form 13F filing with the...

Neurocrine Biosciences, Inc. $NBIX Stock Holdings Increased by Los Angeles Capital Management LLC

Los Angeles Capital Management LLC grew its stake in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 19,454.9% during the 2nd quarter, according to the company in its most...

William Rastetter Sells 18,000 Shares of Neurocrine Biosciences (NASDAQ:NBIX) Stock

Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Get Free Report) Director William Rastetter sold 18,000 shares of the business's stock in a transaction that occurred on Wednesday, November 5th. The...

Neurocrine Biosciences (NASDAQ:NBIX) Director William Rastetter Sells 18,000 Shares

Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Get Free Report) Director William Rastetter sold 18,000 shares of the firm's stock in a transaction on Wednesday, November 5th. The shares were sold at an...

C WorldWide Group Holding A S Acquires 20,000 Shares of Neurocrine Biosciences, Inc. $NBIX

C WorldWide Group Holding A S raised its holdings in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 17.4% in the 2nd quarter, according to the company in its most recent Form...

Earnings Estimates Rising for Neurocrine (NBIX): Will It Gain?

Neurocrine Biosciences (NBIX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Neurocrine Biosciences (NASDAQ:NBIX) Sets New 52-Week High - Should You Buy?

Neurocrine Biosciences (NASDAQ:NBIX) Hits New 1-Year High - Still a Buy...

What Makes Neurocrine (NBIX) a New Strong Buy Stock

Neurocrine (NBIX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Xenon Q3 Loss Narrower Than Expected, Pipeline Development in Focus

XENE reports narrower-than-expected Q3 loss as the biotech advances multiple late-stage studies of azetukalner across epilepsy and mood disorders.

Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research and development, commercialization, and sale of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. Its portfolio of products includes treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia (CAH), and endometriosis and uterine fibroids. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.

Neurocrine Biosciences, Inc.

$NVDA

$MSFT

$AAPL

$GOOGL

Which of these Mag 7 stocks are you most bullish on right now?

NBIX
Neurocrine Biosciences, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest NBIX News

NBIXNeurocrine Biosciences, Inc.